Note 15 - Debt - Accounts Receivable Programs (Details) $ in Thousands, € in Millions |
12 Months Ended | ||||||||
|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2020
USD ($)
|
Dec. 31, 2020
EUR (€)
|
Dec. 31, 2019
USD ($)
|
|||||||
| Amount outstanding | $ 2,121,000 | $ 2,389,000 | |||||||
| Approximate maximum funding availability under all A/R programs | 123,000 | ||||||||
| Approximate amount outstanding under all A/R programs | $ 0 | ||||||||
| US A/R Program [Member] | |||||||||
| Maturity | Apr. 30, 2022 | ||||||||
| Maximum funding availability | [1] | $ 150,000 | |||||||
| Amount outstanding | [2] | $ 0 | |||||||
| US A/R Program [Member] | London Interbank Offered Rate (LIBOR) [Member] | |||||||||
| Interest rate | [3] | 0.90% | |||||||
| EU A/R Program [Member] | |||||||||
| Maturity | Apr. 30, 2022 | ||||||||
| Maximum funding availability | € | [1] | € 100 | |||||||
| Amount outstanding | € | € 0 | ||||||||
| EU A/R Program [Member] | GBP LIBOR, USD LIBOR or EURIBOR [Member] | |||||||||
| Interest rate | [3] | 1.30% | |||||||
| |||||||||
| X | ||||||||||
- Definition Represents an approximation of the amount outstanding under all A/R programs. No definition available.
|
| X | ||||||||||
- Definition Represents the approximate amount of maximum funding available under all A/R programs. No definition available.
|
| X | ||||||||||
- Definition The amount of maximum funding availability. No definition available.
|
| X | ||||||||||
- Definition Percentage points added to the reference rate to compute the variable rate on the debt instrument. No definition available.
|
| X | ||||||||||
- Definition Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|